Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$3.57M Sell
75,844
-26,326
-26% -$1.4M 3.29% 4
2015
Q2
$5.55M Buy
102,170
+6,419
+7% +$360K 2.79% 4
2015
Q1
$5.25M Sell
95,751
-6,026
-6% -$341K 2.36% 5
2014
Q4
$5.51M Sell
101,777
-28,767
-22% -$1.6M 2.05% 6
2014
Q3
$7.38M Sell
130,544
-80,183
-38% -$4.5M 1.91% 7
2014
Q2
$11.6M Sell
210,727
-8,394
-4% -$458K 1.76% 7
2014
Q1
$11.9M Sell
219,121
-3,479
-2% -$180K 1.61% 9
2013
Q4
$10.6M Sell
222,600
-31,776
-12% -$1.45M 1.36% 15
2013
Q3
$11.6M Sell
254,376
-13,288
-5% -$607K 1.43% 13
2013
Q2
$11.9M Buy
+267,664
New +$12M 1.38% 15

Other funds holding MRK

Platte River Capital's MRK Position: Q3 2015 in Review

Platte River Capital reduced its Merck (MRK) stake by 26% in Q3 2015, selling an estimated $1.4M and leaving 75,844 shares worth $3.57M. The position accounts for 3.29% of the portfolio, ranked #4.

Platte River Capital first reported a position in MRK in Q2 2013 and has held it in 10 quarters since. The position peaked at $11.9M in Q1 2014. 1,672 funds tracked by Wall St. Rank hold MRK as of Q3 2015.

  • Platte River Capital held 75,844 shares of Merck worth $3.57M as of Q3 2015.
  • Platte River Capital sold 26,326 Merck shares in Q3 2015, an estimated $1.4M.
  • Merck made up 3.29% of Platte River Capital's portfolio in Q3 2015, its #4 holding.
  • Platte River Capital first reported a position in Merck in Q2 2013 and has held it in 10 quarters since.
  • Platte River Capital's Merck position peaked at $11.9M in Q1 2014.
  • 1,672 funds tracked by Wall St. Rank held Merck as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.